EFTA Document EFTA01447256

As of 5/8/14 2:10 pm Description Trade Date Quantity Current Price Unit Cost Market Value Current Total Cost Unrealized G/L SANGAMO BIOSCIENCES 5/28/2013 50,000.00 $ 12.17 $ 8.44 $ 608,500.00 422,214.00 186,286.00 BIOGEN 2/14/2012 2,095.00 $ 285.28 $ 119.55 $ 597,661.60 250,454.95 $ 347,206.65 FOUNDATION MEDICINE 1/13/2014 25,000.00 $ 24.13 $ 27.51 $ 603,250.00 687,663.50 S (84,413.50) GILEAD SCIENCES INC Multiple 8,100.00 $ 79.36 $ 79.41 $ 642,816.00 643,204.00 $ (388.00) Total Biotech $ 2,452,227.60 $ 2,003,536.45 $ 448,691.15 ARIAD PHARMACEUTICALS Multiple 16,535.00 $ 6.76 $ 17.60 $ 111,776.60 290,997.40 $ (179,220.80) PX_LAST CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) CONFIDENTIAL DB-SDNY-0101837 SDNY_GM_00248021 EFTA01447256